Second Amendment to the Loan and Security Agreement, dated March 28, 2025, by and between Maze Therapeutics, Inc. and Banc of California
Exhibit 10.17
SECOND AMENDMENT TO
LOAN AND SECURITY AGREEMENT
This Second Amendment to Loan and Security Agreement (this “Amendment”) is entered into as of March 28, 2025, by and between BANC OF CALIFORNIA, a California state-chartered bank (“Bank”), and MAZE THERAPEUTICS, INC., a Delaware corporation (“Borrower”).
RECITALS
A. Borrower and Bank are parties to that certain Loan and Security Agreement dated as of June 27, 2022, as amended by that certain First Amendment and Waiver to Loan and Security Agreement dated as of March 25, 2024 (as the same may be further amended, restated, supplemented, or otherwise modified from time to time, collectively, the “Agreement”).
B. Borrower and Bank agree that Borrower has achieved the Funding Milestone.
C. Borrower and Bank wish to amend certain provisions of the Agreement in accordance with the terms of this Amendment.
NOW, THEREFORE, the parties agree as follows:
(c) Conversion into Term Loan. The aggregate principal amount of the Advances outstanding on the Revolving Maturity Date shall, at Borrower’s option, convert into a Term Loan (the “Term Loan”). Any Advances not converted to into a Term Loan shall be due and payable on the Revolving Maturity Date, together with any interest outstanding on such Advances. Any Term Loan that is outstanding on June 27, 2026, shall be payable in eighteen (18) equal monthly installments of principal, plus all accrued interest, beginning on July 27, 2026, and continuing on the same day of each month thereafter through the Maturity Date, at which time all amounts outstanding under this Agreement shall be immediately due and payable. Borrower may prepay all or any part of the Term Loan, but no amount, once repaid, may be reborrowed.
(b) Interest Rates. Except as set forth in Section 2.3(a), the Advances or Term Loan, as applicable, shall bear interest, on the outstanding daily balance thereof, at a variable annual rate equal to the greater of: (A) 0.75% above the Prime Rate then in effect; and (B) 4.50%.
(c) Payments. Interest under the Revolving Line or Term Loan, as applicable, shall be due and payable on the 27th calendar day of each month during the term hereof. Borrower authorizes Bank to, at its option, charge such interest, all Bank Expenses, all Periodic Payments, and any other amounts due and owing in accordance with the terms of this Agreement against any of Borrower’s deposit accounts or against the Revolving Line, in which case those amounts shall thereafter accrue interest at the rate then applicable hereunder. Any interest not
1
paid when due shall be compounded by becoming a part of the Obligations, and such interest shall thereafter accrue interest at the rate then applicable hereunder.
“Maturity Date” means December 27, 2027.
“Revolving Maturity Date” means June 27, 2026.
2
[REMAINDER OF PAGE INTENTIONALLY LEFT BLANK]
3
[SIGNATURE PAGE TO SECOND AMENDMENT TO LOAN AND SECURITY AGREEMENT]
IN WITNESS WHEREOF, the undersigned have executed this Amendment as of the first date above written.
MAZE THERAPEUTICS, INC.
By: /s/ Jason Coloma
Name: Jason Coloma, Ph.D.
Title: Chief Executive Officer
BANC OF CALIFORNIA
By:/s/ Steve Kent
Name: Steve Kent
Title: Vice President